Clabo SpA
MIL:CLA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Clabo SpA
MIL:CLA
|
IT |
|
Immunome Inc
NASDAQ:IMNM
|
US |
|
G
|
GAIL (India) Ltd
BSE:532155
|
IN |
|
E
|
EEMS Italia SpA
MIL:EEMS
|
IT |
|
P
|
Practical Solution PCL
SET:TPS
|
TH |
|
Sumber Tani Agung Resources Tbk PT
IDX:STAA
|
ID |
|
Premium Resources Ltd
XTSX:PREM
|
CA |
|
A
|
Ainsworth Game Technology Ltd
ASX:AGI
|
AU |
|
SeQuent Scientific Ltd
NSE:SEQUENT
|
IN |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CLA's stock price target?
Not Available
CLA doesn't have any price targets made by Wall Street professionals.
What is Clabo SpA's Revenue forecast?
Projected CAGR
9%
For the last 1 year the
compound annual growth rate for
Clabo SpA's revenue is
16%.
The projected
CAGR
for the next 2 years is
9%.
What is Clabo SpA's Operating Income forecast?
Projected CAGR
20%
For the last 1 year the
compound annual growth rate for
Clabo SpA's operating income is
298%.
The projected
CAGR
for the next 2 years is
20%.
What is Clabo SpA's Net Income forecast?
Projected CAGR
159%
The
compound annual growth rate
of Clabo SpA's net income for the next 2 years is
159%.
